HANESBRANDS INC (HBI)

US4103451021 - Common Stock

4.65  -0.08 (-1.69%)

After market: 4.64 -0.01 (-0.22%)

Fundamental Rating

3

HBI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. HBI has a bad profitability rating. Also its financial health evaluation is rather negative. HBI has a valuation in line with the averages, but on the other hand it scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year HBI was profitable.
In the past year HBI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: HBI reported negative net income in multiple years.
HBI had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

HBI has a worse Return On Assets (-0.31%) than 62.00% of its industry peers.
With a Return On Equity value of -4.23%, HBI is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
HBI has a Return On Invested Capital of 7.52%. This is in the better half of the industry: HBI outperforms 66.00% of its industry peers.
HBI had an Average Return On Invested Capital over the past 3 years of 10.94%. This is in line with the industry average of 10.01%.
Industry RankSector Rank
ROA -0.31%
ROE -4.23%
ROIC 7.52%
ROA(3y)-0.39%
ROA(5y)1.2%
ROE(3y)-8.39%
ROE(5y)2.82%
ROIC(3y)10.94%
ROIC(5y)11.34%

1.3 Margins

Looking at the Operating Margin, with a value of 7.18%, HBI is in line with its industry, outperforming 52.00% of the companies in the same industry.
HBI's Operating Margin has declined in the last couple of years.
HBI has a worse Gross Margin (34.92%) than 76.00% of its industry peers.
In the last couple of years the Gross Margin of HBI has declined.
Industry RankSector Rank
OM 7.18%
PM (TTM) N/A
GM 34.92%
OM growth 3Y-17.27%
OM growth 5Y-12.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2%
GM growth 5Y-2.46%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HBI is creating some value.
HBI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HBI has been reduced compared to 5 years ago.
Compared to 1 year ago, HBI has an improved debt to assets ratio.

2.2 Solvency

HBI has an Altman-Z score of 1.75. This is a bad value and indicates that HBI is not financially healthy and even has some risk of bankruptcy.
HBI has a worse Altman-Z score (1.75) than 68.00% of its industry peers.
The Debt to FCF ratio of HBI is 6.38, which is on the high side as it means it would take HBI, 6.38 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of HBI (6.38) is worse than 60.00% of its industry peers.
A Debt/Equity ratio of 7.72 is on the high side and indicates that HBI has dependencies on debt financing.
HBI has a worse Debt to Equity ratio (7.72) than 96.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.72
Debt/FCF 6.38
Altman-Z 1.75
ROIC/WACC0.83
WACC9.03%

2.3 Liquidity

HBI has a Current Ratio of 1.64. This is a normal value and indicates that HBI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.64, HBI is doing worse than 66.00% of the companies in the same industry.
A Quick Ratio of 0.65 indicates that HBI may have some problems paying its short term obligations.
HBI has a worse Quick ratio (0.65) than 86.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.65

3

3. Growth

3.1 Past

HBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.88%.
The earnings per share for HBI have been decreasing by -49.01% on average. This is quite bad
The Revenue has decreased by -9.58% in the past year.
The Revenue has been decreasing by -3.69% on average over the past years.
EPS 1Y (TTM)-93.88%
EPS 3Y-65.41%
EPS 5Y-49.01%
EPS growth Q2Q-57.14%
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y-2.74%
Revenue growth 5Y-3.69%
Revenue growth Q2Q-11.98%

3.2 Future

HBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 96.72% yearly.
Based on estimates for the next years, HBI will show a small growth in Revenue. The Revenue will grow by 2.19% on average per year.
EPS Next Y630.57%
EPS Next 2Y229.03%
EPS Next 3Y142.45%
EPS Next 5Y96.72%
Revenue Next Year-6.49%
Revenue Next 2Y-2.25%
Revenue Next 3Y-1.77%
Revenue Next 5Y2.19%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

6

4. Valuation

4.1 Price/Earnings Ratio

HBI is valuated quite expensively with a Price/Earnings ratio of 77.50.
Compared to the rest of the industry, the Price/Earnings ratio of HBI indicates a slightly more expensive valuation: HBI is more expensive than 60.00% of the companies listed in the same industry.
HBI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.76.
A Price/Forward Earnings ratio of 10.61 indicates a reasonable valuation of HBI.
HBI's Price/Forward Earnings ratio is rather cheap when compared to the industry. HBI is cheaper than 82.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.26. HBI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 77.5
Fwd PE 10.61

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HBI is valued a bit cheaper than 62.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HBI is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.16
EV/EBITDA 9.33

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HBI's earnings are expected to grow with 142.45% in the coming years.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y229.03%
EPS Next 3Y142.45%

0

5. Dividend

5.1 Amount

No dividends for HBI!.
Industry RankSector Rank
Dividend Yield N/A

HANESBRANDS INC

NYSE:HBI (4/19/2024, 7:04:00 PM)

After market: 4.64 -0.01 (-0.22%)

4.65

-0.08 (-1.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.63B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 77.5
Fwd PE 10.61
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.31%
ROE -4.23%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.18%
PM (TTM) N/A
GM 34.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 7.72
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.64
Quick Ratio 0.65
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-93.88%
EPS 3Y-65.41%
EPS 5Y
EPS growth Q2Q
EPS Next Y630.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-9.58%
Revenue growth 3Y-2.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y